American Century Companies
TXG icon

American Century Companies’s 10x Genomics TXG Stock Holding History

American Century Companies’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.4M Buy
322,486
+30,285
+10% +$794K 0.01% 1478
2026
Q1 		$6.2M Buy
292,201
+20,547
+8% +$411K ﹤0.01% 1673
2025
Q4 		$4.43M Buy
271,654
+34,216
+14% +$517K ﹤0.01% 1773
2025
Q3 		$2.78M Buy
237,438
+156,840
+195% +$2.04M ﹤0.01% 1946
2025
Q2 		$933K Buy
+80,598
New +$735K ﹤0.01% 2317
2024
Q4 		– Sell
-109,151
Closed -$2.46M – 2955
2024
Q3 		$2.46M Sell
109,151
-22,532
-17% -$466K ﹤0.01% 1882
2024
Q2 		$2.56M Sell
131,683
-36,547
-22% -$957K ﹤0.01% 1805
2024
Q1 		$6.31M Sell
168,230
-5,340
-3% -$235K ﹤0.01% 1386
2023
Q4 		$9.71M Buy
173,570
+4,573
+3% +$199K 0.01% 1161
2023
Q3 		$6.97M Sell
168,997
-458
-0.3% -$23.8K 0.01% 1206
2023
Q2 		$9.46M Buy
169,455
+17,576
+12% +$951K 0.01% 1072
2023
Q1 		$8.47M Buy
151,879
+23,647
+18% +$1.1M 0.01% 1074
2022
Q4 		$4.67M Buy
128,232
+22,893
+22% +$749K ﹤0.01% 1247
2022
Q3 		$3M Buy
105,339
+29,125
+38% +$1.11M ﹤0.01% 1289
2022
Q2 		$3.45M Sell
76,214
-42,537
-36% -$2.21M ﹤0.01% 1244
2022
Q1 		$9.03M Sell
118,751
-621,499
-84% -$54.4M 0.01% 943
2021
Q4 		$110M Sell
740,250
-42,433
-5% -$6.5M 0.07% 293
2021
Q3 		$114M Buy
782,683
+63,720
+9% +$10.9M 0.08% 265
2021
Q2 		$141M Buy
718,963
+38,947
+6% +$7.05M 0.1% 232
2021
Q1 		$123M Buy
680,016
+418,213
+160% +$72.2M 0.09% 261
2020
Q4 		$37.1M Buy
261,803
+223,728
+588% +$32.5M 0.03% 463
2020
Q3 		$4.75M Buy
38,075
+6,830
+22% +$717K ﹤0.01% 810
2020
Q2 		$2.79M Buy
31,245
+18,907
+153% +$1.47M ﹤0.01% 842
2020
Q1 		$769K Sell
12,338
-28,814
-70% -$2.25M ﹤0.01% 1052
2019
Q4 		$3.14M Sell
41,152
-48,662
-54% -$2.93M ﹤0.01% 870
2019
Q3 		$4.53M Buy
+89,814
New +$4.97M ﹤0.01% 824

Other funds holding TXG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

American Century Companies's TXG Position: Q2 2026 in Review

American Century Companies increased its 10x Genomics (TXG) stake by 10% in Q2 2026, buying an estimated $794K and bringing the position to 322,486 shares worth $12.4M. The position accounts for 0.01% of the portfolio, ranked #1478.

American Century Companies first reported a position in TXG in Q3 2019 and has held it in 26 quarters since. The position peaked at $141M in Q2 2021. 368 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • American Century Companies held 322,486 shares of 10x Genomics worth $12.4M as of Q2 2026.
  • American Century Companies bought 30,285 10x Genomics shares in Q2 2026, an estimated $794K.
  • 10x Genomics made up 0.01% of American Century Companies's portfolio in Q2 2026, its #1478 holding.
  • American Century Companies first reported a position in 10x Genomics in Q3 2019 and has held it in 26 quarters since.
  • American Century Companies's 10x Genomics position peaked at $141M in Q2 2021.
  • 368 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.